A new study from Children’s Hospital of Philadelphia (CHOP) showed promising results for Pediatric Hodgkin Lymphoma (pHL) patients who underwent proton therapy to treat their disease in rare regions located below the diaphragm, such as the abdomen and pelvis. The study highlights the advantages of proton therapy over conventional photon radiotherapy, demonstrating fewer side effects and better protection for critical organs. It was published recently in the journal Pediatric Blood and Cancer.

Proton therapy at CHOP helped Elena regain her vision and remain free of craniopharyngioma two years after treatment.

A collaborative effort transformed the proton therapy facility into colorful rooms with unique themes and helped replace patients’ anxiety with anticipation.

Proton therapy for a 3-year-old with neuroblastoma compared to X-ray therapy allowed a 100-fold reduction in radiation dose to the liver, lungs, and heart.